Profil
Johan Malmsten is currently the Chairman of The Richard C.
Malmsten Memorial Foundation and a Director at Supratek Pharma, Inc. He previously served as Chairman of Alzpharm AB, Director of Meda AB, Director of Din Bostad Sverige AB, Director of Stille AB, Director of Safelogic AB, and Managing Director of Malmsten Invest AB.
Aktive Positionen von Johan Malmsten
| Unternehmen | Position | Beginn |
|---|---|---|
The Richard C. Malmsten Memorial Foundation | Vorsitzender | - |
Ehemalige bekannte Positionen von Johan Malmsten
| Unternehmen | Position | Ende |
|---|---|---|
Alzpharm AB | Vorsitzender | - |
Din Bostad Sverige AB
Din Bostad Sverige AB Real Estate DevelopmentFinance Operates a residential property business | Direktor/Vorstandsmitglied | - |
Malmsten Invest AB
Malmsten Invest AB Financial ConglomeratesFinance Provides investment services for life sciences enterprises | Vorstandsvorsitzender | - |
| STILLE AB | Direktor/Vorstandsmitglied | - |
Safelogic AB
Safelogic AB Packaged SoftwareTechnology Services Develops target design software | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Meda AB
Meda AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Din Bostad Sverige AB
Din Bostad Sverige AB Real Estate DevelopmentFinance Operates a residential property business | Finance |
Stille AB
Stille AB Medical SpecialtiesHealth Technology Develops, manufactures and distributes surgical instruments | Health Technology |
Safelogic AB
Safelogic AB Packaged SoftwareTechnology Services Develops target design software | Technology Services |
Supratek Pharma, Inc.
Supratek Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and related oncology therapeutic products | Health Technology |
Malmsten Invest AB
Malmsten Invest AB Financial ConglomeratesFinance Provides investment services for life sciences enterprises | Finance |
The Richard C. Malmsten Memorial Foundation | |
Alzpharm AB |
















